Keyphrases
4E-BP1
16%
Ablation
16%
Altered Gene Expression
16%
Cap-dependent
16%
Cap-independent
16%
Causes of Blindness
16%
Complex Assembly
50%
Diabetes
33%
Diabetic
16%
Diabetic Mouse Model
16%
Diabetic Retinopathy
83%
EIF4A
16%
EIF4F Complex
50%
EIF4G1
16%
Evidence-based Treatment
16%
Gene Expression Pattern
16%
Gene Regulation
100%
Hexosamine Pathway
16%
Hyperglycemia
100%
Insulin
16%
Internal Ribosome Entry Site
16%
Metabolic Abnormalities
16%
Molecular Pathology
16%
Neurovascular Complications
16%
New Targets
33%
Non-destructive
16%
Novel Mechanism
16%
O-GlcNAcylation
50%
O-linked N-acetylglucosamine (O-GlcNAc)
16%
Pathophysiology
16%
Physiological Changes
16%
Poly(A)-binding Protein
16%
Preclinical Stage
16%
Proliferative Diabetic Retinopathy
16%
Retina
100%
Structural Change
16%
Technical Expertise
16%
Therapeutic Intervention
16%
Threonine
16%
Translation Initiation Factor
16%
Translational Control
100%
United States
16%
Vascular Growth Factor
33%
Working Population
16%
Medicine and Dentistry
Biosynthesis
16%
Diabetes
50%
Diabetic Retinopathy
83%
Diseases
50%
Gene Expression
100%
Growth Factor
33%
Hexosamine
16%
Hyperglycemia
100%
Initiation Factor
16%
Initiation Factor 4E
16%
Initiation Factor 4G
16%
Internal Ribosome Entry Site
16%
Molecular Pathology
16%
Pathophysiology
16%
Proliferative Diabetic Retinopathy
16%
Protein Binding
16%
RNA Translation
33%
Serine
16%
Synapsin I
16%
Threonine
16%
Pharmacology, Toxicology and Pharmaceutical Science
Binding Protein
16%
Diabetic Retinopathy
83%
Diseases
50%
Growth Factor
33%
Hexosamine
16%
Hyperglycemia
100%
Initiation Factor
16%
Initiation Factor 4A
16%
Initiation Factor 4E
16%
Initiation Factor 4F
50%
Initiation Factor 4G
16%
Molecular Pathology
16%
Mouse Model
16%
N Acetylglucosamine
16%
Pathophysiology
16%
Proliferative Diabetic Retinopathy
16%
Serine
16%
Synapsin I
16%
Threonine
16%